Promotions & Moves

Endo Seeks New CFO

Upadhyay to depart, Coleman to fill in on interim basis

Suketu Upadhyay, executive vice president and chief financial officer, is leaving Endo International, effective November 22, to assume a senior-level finance position at a global biopharmaceutical company. Blaise Coleman, Endo’s senior vice president of Global Finance Operations, will serve as interim chief financial officer. The company will begin a search for a permanent successor.


“We would like to thank Suky for his dedicated service to Endo, his role in transforming the Company and in building a strong Finance organization. We wish him the very best in his professional endeavors and much continued success,” said Paul Campanelli, president and chief executive officer of Endo. “We recently reaffirmed Endo’s third quarter and full year 2016 financial guidance and we remain confident in our 2016 performance. I look forward to working with Suky through his transition and closely with Blaise as we complete a product-by-product assessment of our portfolio and further sharpen Endo’s strategy and operational focus.”

“My time at Endo has been pivotal for my career and I am very proud of the best-in-class teams I have built and led for the Company while contributing to the transformation of Endo since 2013,” said Mr. Upadhyay. “I want to thank Paul for the past year of collaboration and for the confidence he and the Board have put in my abilities. I am confident that Paul’s and the leadership team’s focus on execution will drive success for the Company into the future.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters